Inovio Pharmaceuticals Inc (INO)
4.07
+0.01
(+0.25%)
USD |
NASDAQ |
Nov 22, 16:00
4.08
+0.01
(+0.25%)
Pre-Market: 20:00
Inovio Pharmaceuticals Cash from Operations (Quarterly): -27.44M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -27.44M |
| June 30, 2024 | -28.21M |
| March 31, 2024 | -28.76M |
| December 31, 2023 | -26.28M |
| September 30, 2023 | -29.11M |
| June 30, 2023 | -32.31M |
| March 31, 2023 | -36.66M |
| December 31, 2022 | -36.34M |
| September 30, 2022 | -67.47M |
| June 30, 2022 | -50.53M |
| March 31, 2022 | -61.88M |
| December 31, 2021 | -37.89M |
| September 30, 2021 | -46.49M |
| June 30, 2021 | -78.46M |
| March 31, 2021 | -52.87M |
| December 31, 2020 | -51.22M |
| September 30, 2020 | -74.16M |
| June 30, 2020 | -27.15M |
| March 31, 2020 | -25.45M |
| December 31, 2019 | -13.74M |
| September 30, 2019 | -27.73M |
| June 30, 2019 | -23.92M |
| March 31, 2019 | -32.45M |
| December 31, 2018 | -17.28M |
| September 30, 2018 | -24.67M |
| Date | Value |
|---|---|
| June 30, 2018 | -19.02M |
| March 31, 2018 | -12.58M |
| December 31, 2017 | -13.95M |
| September 30, 2017 | -17.31M |
| June 30, 2017 | -16.72M |
| March 31, 2017 | -15.23M |
| December 31, 2016 | -14.90M |
| September 30, 2016 | -18.64M |
| June 30, 2016 | -13.27M |
| March 31, 2016 | -15.74M |
| December 31, 2015 | -6.774M |
| September 30, 2015 | 15.42M |
| June 30, 2015 | -9.022M |
| March 31, 2015 | -12.07M |
| December 31, 2014 | -8.074M |
| September 30, 2014 | -8.043M |
| June 30, 2014 | -8.148M |
| March 31, 2014 | -5.557M |
| December 31, 2013 | 0.8749M |
| September 30, 2013 | -5.704M |
| June 30, 2013 | -5.422M |
| March 31, 2013 | -5.130M |
| December 31, 2012 | -5.522M |
| September 30, 2012 | -6.033M |
| June 30, 2012 | -5.314M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-78.46M
Minimum
Jun 2021
-13.74M
Maximum
Dec 2019
-41.62M
Average
-36.50M
Median
Cash from Operations (Quarterly) Benchmarks
| Novavax Inc | -144.81M |
| Baxter International Inc | 253.00M |
| AIM ImmunoTech Inc | -3.11M |
| Protalix BioTherapeutics Inc | 4.105M |
| Armata Pharmaceuticals Inc | -8.863M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 14.08M |
| Cash from Financing (Quarterly) | 0.6606M |
| Free Cash Flow | -111.18M |
| Free Cash Flow Per Share (Quarterly) | -0.9752 |
| Free Cash Flow Yield | -107.8% |